Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Remifentanil and Dexmedetomidine for Postoperative Pain in Spinal Surgery
NCT06264739Recruiting
- Sponsor
- Aydın Adnan Menderes University
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in pain (2 arms), sponsored by Aydın Adnan Menderes University. Primary endpoint: Opioid Consumption at 24 hours. Started Jan 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06264739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06264739.